On October 24th, OBIO's Health Economics Day workshop, hosted in partnership with St. Michael’s Hospital on October 24th, was a great success.
Encycle Therapeutics, a Toronto-based drug discovery company, announced a research collaboration with Pfizer to optimize certain nacellins.
This week, VBI Vaccines announced the closing of its public offering which raised approximately US$71.9 Million.
Profound Medical Corp. announced this week that treatments utilizing its TULSA-PRO® technology of Benign Prostatic Hyperplasia (“BPH”) are now being successfully conducted in Germany.
Tieös Pharmaceuticals, a next-generation biotech company focused on cancer metabolic therapies, was selected as a finalist in the 2017 BioInnovation Challenge being held in Halifax, Nova Scotia.
VivaVax is an early-stage life sciences company creating biosafe formulations to protect sensitive medicines from heat fluctuations during transport.
Last week they won the Vinetta Project Finals, which includes a cash prize of $15K, and $25K in legal support from Blakes.
Komodo OpenLabs (CAAP 2015) has won 1st Place at the highly competitive 2017 Interface Health Challenge with their TECLA line.
The prize has a total value of $40K and includes cash, services, and media. Their flagship TECLA product line helps those with physical disabilities effectively use modern day communications devices such as smartphones and tablets.
Mark Elias, Co founder and CEO was featured on CTV's MedicalWatch segment, demonstrating the company's battery-free Steadiglove technology.
Colin Harding, CEO of Iris Technologies authoured a blog featured on the BIST website. Iris Technologies has developed a unique e-reader solution helps people who have suffered from a mild traumatic brain injury (MTBI) or live with chronic migraines regain their ability to comfortably read electronic documents, and assist in their recovery process.
Former MP for Kingston and the Islands Ted Hsu has been spending lots of time with his family since leaving politics behind in 2015, but now he is ready to take on a new challenge.
Hsu is the newest member of SYNG Pharmaceuticals, a Kingston-based company that is looking to help diagnose and treat endometriosis.